PPAR Agonists and Cardiovascular Disease in Diabetes

PPAR Research - Egypt
doi 10.1155/2008/245410
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Effect of PPAR-y Agonists on Macrophage Activation in Type2 Diabetes Mellitus

Journal of Clinical and Analytical Medicine
Medicine
2018English

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease

PPAR Research
Drug DiscoveryPharmacology
2008English

Diabetes Mellitus and Cardiovascular Disease

Journal of Clinical & Experimental Cardiology
2011English

MicroRNAs and Cardiovascular Disease in Diabetes Mellitus

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Differential Antiatherogenic Effects of PPAR Versus PPAR Agonists: Should We Be Surprised?

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2005English

Lipids, Thrombosis and Cardiovascular Disease in Diabetes

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1997English

Diabetes, Cardiovascular Disease and the Microcirculation

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

The Effect of High Glucose and PPAR- Agonists on PPAR- Expression and Function in HK-2 Cells

AJP: Renal Physiology
2004English

PPAR Agonists: Potential as Therapeutics for Neovascular Retinopathies

PPAR Research
Drug DiscoveryPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy